Re-examining remission definitions in rheumatoid arthritis: considering the 28-Joint Disease Activity Score, C-reactive protein level and patient global assessment-Reference-Cited by-同舟云学术

Re-examining remission definitions in rheumatoid arthritis: considering the 28-Joint Disease Activity Score, C-reactive protein level and patient global assessment

Published:2021-11-16 Issue:1 Volume:81 Page:4-7
ISSN:0003-4967
Container-title:Annals of the Rheumatic Diseases
language:en
Short-container-title:Ann Rheum Dis

Author:

Felson David^ORCID,Lacaille Diane,LaValley Michael P,Aletaha Daniel^ORCID

Funder

NIHR Manchester BRC

NIH

National insitutes of Health

Publisher

BMJ

Subject

General Biochemistry, Genetics and Molecular Biology,Immunology,Immunology and Allergy,Rheumatology

Reference20 articles.

1. American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials

2. American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

3. A simplified disease activity index for rheumatoid arthritis for use in clinical practice

4. Modified disease activity scores that include twenty-eight-joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis

5. Update of the American College of rheumatology recommended rheumatoid arthritis disease activity measures;England;Arthritis Care Res,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoantibodies to joint-related peptides as predictive markers in early rheumatoid arthritis;Rheumatology;2024-07-30

2. RheuMetric Quantitative 0 to 10 Physician Estimates of Inflammation, Damage, and Distress in Rheumatoid Arthritis: Validation Against Reference Measures;ACR Open Rheumatology;2023-08-22

3. Patient global assessment is elevated by up to 5 of 10 units in patients with inflammatory arthritis who screen positive for fibromyalgia (by FAST4) and/or depression (by MDS2) on a single MDHAQ;Seminars in Arthritis and Rheumatism;2023-02

4. A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis;BMC Rheumatology;2022-12-09

5. China rheumatoid arthritis registry of patients with Chinese medicine (CERTAIN): Rationale, design, and baseline characteristics of the first 11,764 enrollees;Phytomedicine;2022-09